These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 38889541)

  • 1. Advancements in Biosensors for Point-of-Care Testing of Nucleic Acid.
    Ming T; Lan T; Yu M; Cheng S; Duan X; Wang H; Deng J; Kong D; Yang S; Shen Z
    Crit Rev Anal Chem; 2024 Jun; ():1-16. PubMed ID: 38889541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the use of nanomaterials for nucleic acid detection in point-of-care testing devices: A review.
    He Z; Liu C; Li Z; Chu Z; Chen X; Chen X; Guo Y
    Front Bioeng Biotechnol; 2022; 10():1020444. PubMed ID: 36312553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advancements in magnetic nanoparticle-based biosensors for point-of-care testing.
    Wang M; Jin L; Hang-Mei Leung P; Wang-Ngai Chow F; Zhao X; Chen H; Pan W; Liu H; Li S
    Front Bioeng Biotechnol; 2024; 12():1393789. PubMed ID: 38725992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microfluidic-assisted integrated nucleic acid test strips for POCT.
    Wang N; Zhang J; Xiao B; Chen A
    Talanta; 2024 Jan; 267():125150. PubMed ID: 37672986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paper-Based Biosensors for the Detection of Nucleic Acids from Pathogens.
    Wang J; Davidson JL; Kaur S; Dextre AA; Ranjbaran M; Kamel MS; Athalye SM; Verma MS
    Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internet of medical things (IoMT)-integrated biosensors for point-of-care testing of infectious diseases.
    Jain S; Nehra M; Kumar R; Dilbaghi N; Hu T; Kumar S; Kaushik A; Li CZ
    Biosens Bioelectron; 2021 May; 179():113074. PubMed ID: 33596516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidics-Based Point-of-Care Testing (POCT) Devices in Dealing with Waves of COVID-19 Pandemic: The Emerging Solution.
    Kumar A; Parihar A; Panda U; Parihar DS
    ACS Appl Bio Mater; 2022 May; 5(5):2046-2068. PubMed ID: 35473316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis and mapping of global research publications on point-of-care testing for infectious diseases.
    Sweileh WM
    J Eval Clin Pract; 2024 Sep; 30(6):945-953. PubMed ID: 38764304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
    Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
    Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus Detection: From State-of-the-Art Laboratories to Smartphone-Based Point-of-Care Testing.
    Xiao M; Tian F; Liu X; Zhou Q; Pan J; Luo Z; Yang M; Yi C
    Adv Sci (Weinh); 2022 Jun; 9(17):e2105904. PubMed ID: 35393791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality Management for Point-Of-Care Testing of Pathogen Nucleic Acids: Chinese Expert Consensus.
    Mo X; Wang X; Zhu Z; Yu Y; Chang D; Zhang X; Li D; Sun F; Zhou L; Xu J; Zhang H; Gao C; Guan M; Xiao Y; Wu W
    Front Cell Infect Microbiol; 2021; 11():755508. PubMed ID: 34722341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis Screening and Treatment Campaign in Malaysia-Validation of Low-cost Point of Care Screening Tests and Nucleic Acid Tests for Hepatitis B and C.
    Radzi Ah M; S Tan S; Mohamed R; Jaya F; K S; C Aun A; A Kutty G; S Wong H; Abdullah R; R Seman M; Al Mahtab M; Morad Z; Lim TO
    Euroasian J Hepatogastroenterol; 2018; 8(2):101-107. PubMed ID: 30828549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanomaterial-mediated paper-based biosensors for colorimetric pathogen detection.
    Nguyen QH; Kim MI
    Trends Analyt Chem; 2020 Nov; 132():116038. PubMed ID: 32958969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in Nanomaterial-Based Biosensors for Point-of-Care Testing.
    Wang X; Li F; Guo Y
    Front Chem; 2020; 8():586702. PubMed ID: 33195085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2 Based on Nucleic Acid Amplification Tests (NAATs) and Its Integration into Nanomedicine and Microfluidic Devices as Point-of-Care Testing (POCT).
    Dorta-Gorrín A; Navas-Méndez J; Gozalo-Margüello M; Miralles L; García-Hevia L
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging point-of-care biosensors for rapid diagnosis of COVID-19: current progress, challenges, and future prospects.
    Rasmi Y; Li X; Khan J; Ozer T; Choi JR
    Anal Bioanal Chem; 2021 Jul; 413(16):4137-4159. PubMed ID: 34008124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Short Review on Miniaturized Biosensors for the Detection of Nucleic Acid Biomarkers.
    Kulkarni MB; Ayachit NH; Aminabhavi TM
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Machine Learning Assisted Biosensors in Point-of-Care-Testing For Clinical Decisions.
    Bhaiyya M; Panigrahi D; Rewatkar P; Haick H
    ACS Sens; 2024 Sep; 9(9):4495-4519. PubMed ID: 39145721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced Point-of-Care Testing Technologies for Human Acute Respiratory Virus Detection.
    Zhang Z; Ma P; Ahmed R; Wang J; Akin D; Soto F; Liu BF; Li P; Demirci U
    Adv Mater; 2022 Jan; 34(1):e2103646. PubMed ID: 34623709
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.